FTC Blesses Daiichi Sankyo's $805M Plexxikon Buy
The Federal Trade Commission on Tuesday granted an early termination to its antitrust review of Daiichi Sankyo Co. Ltd.'s proposed $805 million purchase of Plexxikon Inc., a private Berkeley, Calif.-based pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article